Results 291 to 300 of about 107,975 (358)

Antihypertensive medications and cancer risk: Evidence from 0.27 million patients with newly diagnosed hypertension. [PDF]

open access: yesFront Pharmacol
Yu H   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Newer antihypertensive agents

Postgraduate Medicine, 1991
Three recent additions to the list of antihypertensive agents have been approved for use as monotherapy or in combination with other drugs. Betaxolol hydrochloride (Kerlone) maintains its effect for 24 hours, making it a true once-a-day beta blocker. Penbutolol sulfate (Levatol) is as effective as other beta blockers and diuretics.
Aixa M. Rey, Ken Grauer, John G. Gums
openaire   +3 more sources

Novel antihypertensive agents

Expert Opinion on Investigational Drugs, 2004
Coronary heart disease and cerebrovascular disease continue to be the leading causes of illness and death among adults from developed countries. Their prevalence is strongly related to the effects of many different risk factors, including high blood pressure, cigarette smoking, dyslipidaemia and diabetes.
Luis M. Ruilope, Cristina Sierra
openaire   +3 more sources

Antihypertensive agents

Journal of PeriAnesthesia Nursing, 1999
Fifty million Americans suffer from hypertension. During the perioperative period, hypertension is a frequent finding owing to a variety of mechanisms including anxiety, pain, and preexisting conditions. This article explores the pharmaceutical agents commonly used in the treatment of hypertension. Particular attention is directed to drugs administered
openaire   +2 more sources

Nephroprotection by Antihypertensive Agents

Journal of Cardiovascular Pharmacology, 1994
Arterial hypertension is one of the few factors confirmed to accelerate the development of renal failure. Conversely, several studies have documented that systematic reduction of the blood pressure slows the progression of renal failure. It is postulated that 24-h reduction of the blood pressure should be achieved, best controlled by ambulatory blood ...
openaire   +3 more sources

L-Arginine as an Antihypertensive Agent

Journal of Cardiovascular Pharmacology, 1992
L-Arginine, the precursor of endothelium-derived relaxing factor (EDRF)/nitric oxide (NO), was administered intravenously in five patients with essential hypertension, one with renovascular hypertension, one with primary aldosteronism, and one with Cushing's syndrome. During the administration, the mean arterial pressure decreased concomitantly with an
Hiromichi Suzuki   +4 more
openaire   +3 more sources

Nitrendipine as an antihypertensive agent

European Heart Journal, 1987
A double-blind, stratified and randomized multicentre trial was carried out to compare the antihypertensive efficacy of nitrendipine with that of propranolol. The dose of nitrendipine was 5-20 mg b.d., and of propranolol, 40-120 mg b.d. With nitrendipine (N = 137), systolic blood pressure (SBP) and diastolic blood pressure (DBP) fell from 156 +/- 1 to ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy